全球医药领先品牌_肿瘤特效药_抗癌新药_靶向药物_全球医药咨询-【健康光环全球医药】 -

Oncology

The latest prices for a box of different versions of Amivantamab are announced

2025-10-19 11:44:20

Check Details

Where can I buy Amivantamab more reliably?

2025-10-19 11:44:20

Check Details

Is Amivantamab available in China? Is it easy to buy? _ Kanghule

2025-10-19 11:44:20

Check Details

The correct way to purchase Amivantamab

2025-10-19 11:44:20

Check Details

Can larotrectinib effectively treat the disease?

2025-10-19 11:44:20

Introduction: On November 26, 2018, the U.S. Food and Drug Administration granted accelerated approval to larotrectinib for the treatment of adult and pediatric patients with solid tumors that have neurotrophic receptor tyrosine kinase (NTRK) gene fusions, no known acquired resistance mutations, have metastasized or where surgical resection may result in severe morbidity, and have no satisfactory alternative treatments or whose cancer has progressed after treatment.

Check Details